Open Access
Open access
том 10 издание 2 страницы 274

Pharmacotherapy for Non-Alcoholic Fatty Liver Disease: Emerging Targets and Drug Candidates

Тип публикацииJournal Article
Дата публикации2022-01-26
scimago Q1
wos Q1
БС2
SJR1.114
CiteScore6.8
Impact factor3.9
ISSN22279059
General Biochemistry, Genetics and Molecular Biology
Medicine (miscellaneous)
Краткое описание

Non-alcoholic fatty liver disease (NAFLD), or metabolic (dysfunction)-associated fatty liver disease (MAFLD), is characterized by high global incidence and prevalence, a tight association with common metabolic comorbidities, and a substantial risk of progression and associated mortality. Despite the increasingly high medical and socioeconomic burden of NAFLD, the lack of approved pharmacotherapy regimens remains an unsolved issue. In this paper, we aimed to provide an update on the rapidly changing therapeutic landscape and highlight the major novel approaches to the treatment of this disease. In addition to describing the biomolecules and pathways identified as upcoming pharmacological targets for NAFLD, we reviewed the current status of drug discovery and development pipeline with a special focus on recent evidence from clinical trials.

Найдено 
Найдено 

Топ-30

Журналы

1
2
3
Signal Transduction and Targeted Therapy
3 публикации, 6.82%
International Journal of Molecular Sciences
2 публикации, 4.55%
Frontiers in Immunology
2 публикации, 4.55%
Medicina
2 публикации, 4.55%
Experimental and Clinical Gastroenterology
2 публикации, 4.55%
Biomedicines
2 публикации, 4.55%
Cureus
2 публикации, 4.55%
Livers
1 публикация, 2.27%
Frontiers in Nutrition
1 публикация, 2.27%
Antioxidants
1 публикация, 2.27%
Scientific Reports
1 публикация, 2.27%
Annals of Medicine and Surgery
1 публикация, 2.27%
Biomedicine and Pharmacotherapy
1 публикация, 2.27%
Heliyon
1 публикация, 2.27%
Immunopharmacology and Immunotoxicology
1 публикация, 2.27%
Life Sciences
1 публикация, 2.27%
Biochimica et Biophysica Acta - Molecular Basis of Disease
1 публикация, 2.27%
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
1 публикация, 2.27%
Life
1 публикация, 2.27%
Egyptian Liver Journal
1 публикация, 2.27%
Frontiers in Endocrinology
1 публикация, 2.27%
Journal of Biochemistry
1 публикация, 2.27%
European Journal of Pharmacology
1 публикация, 2.27%
Journal of Experimental Pharmacology
1 публикация, 2.27%
Clinics and Research in Hepatology and Gastroenterology
1 публикация, 2.27%
Pharmacological Research
1 публикация, 2.27%
New St Petersburg Medical Records
1 публикация, 2.27%
Military Medical Research
1 публикация, 2.27%
Drug Research
1 публикация, 2.27%
1
2
3

Издатели

1
2
3
4
5
6
7
8
9
MDPI
9 публикаций, 20.45%
Elsevier
9 публикаций, 20.45%
Springer Nature
8 публикаций, 18.18%
Frontiers Media S.A.
5 публикаций, 11.36%
Taylor & Francis
4 публикации, 9.09%
LLC Global Media Technology
2 публикации, 4.55%
Oxford University Press
1 публикация, 2.27%
FSBEI HE I.P. Pavlov SPbSMU MOH Russia
1 публикация, 2.27%
Georg Thieme Verlag KG
1 публикация, 2.27%
Baishideng Publishing Group
1 публикация, 2.27%
Edizioni Minerva Medica
1 публикация, 2.27%
1
2
3
4
5
6
7
8
9
  • Мы не учитываем публикации, у которых нет DOI.
  • Статистика публикаций обновляется еженедельно.

Вы ученый?

Создайте профиль, чтобы получать персональные рекомендации коллег, конференций и новых статей.
Метрики
44
Поделиться
Цитировать
ГОСТ |
Цитировать
Prikhodko V. A. et al. Pharmacotherapy for Non-Alcoholic Fatty Liver Disease: Emerging Targets and Drug Candidates // Biomedicines. 2022. Vol. 10. No. 2. p. 274.
ГОСТ со всеми авторами (до 50) Скопировать
Prikhodko V. A., Bezborodkina N. N., Okovityi S. V. Pharmacotherapy for Non-Alcoholic Fatty Liver Disease: Emerging Targets and Drug Candidates // Biomedicines. 2022. Vol. 10. No. 2. p. 274.
RIS |
Цитировать
TY - JOUR
DO - 10.3390/biomedicines10020274
UR - https://doi.org/10.3390/biomedicines10020274
TI - Pharmacotherapy for Non-Alcoholic Fatty Liver Disease: Emerging Targets and Drug Candidates
T2 - Biomedicines
AU - Prikhodko, Veronika A.
AU - Bezborodkina, Natalia N.
AU - Okovityi, Sergey V.
PY - 2022
DA - 2022/01/26
PB - MDPI
SP - 274
IS - 2
VL - 10
PMID - 35203484
SN - 2227-9059
ER -
BibTex |
Цитировать
BibTex (до 50 авторов) Скопировать
@article{2022_Prikhodko,
author = {Veronika A. Prikhodko and Natalia N. Bezborodkina and Sergey V. Okovityi},
title = {Pharmacotherapy for Non-Alcoholic Fatty Liver Disease: Emerging Targets and Drug Candidates},
journal = {Biomedicines},
year = {2022},
volume = {10},
publisher = {MDPI},
month = {jan},
url = {https://doi.org/10.3390/biomedicines10020274},
number = {2},
pages = {274},
doi = {10.3390/biomedicines10020274}
}
MLA
Цитировать
Prikhodko, Veronika A., et al. “Pharmacotherapy for Non-Alcoholic Fatty Liver Disease: Emerging Targets and Drug Candidates.” Biomedicines, vol. 10, no. 2, Jan. 2022, p. 274. https://doi.org/10.3390/biomedicines10020274.